BioVendor’s NGS portfolio is designed to meet the diverse needs of modern laboratories, offering a comprehensive solution built on three key pillars: fastGEN, epicGEN, and the bioinformatics software GENOVESA.
BioVendor brings new technology fastGEN for examination of the mutation status of oncomarkers in samples. Technology is based on ultra-deep sequencing of short amplicons obtained by a single polymerase chain reaction with special tagged hybrid primers.
The fastGEN technology is simple, ultra-sensitive, specific and effective - it is perfectly adapted to diagnostics and offers new advantages for clinical material.
BioVendor introduces epicGEN – a next-generation technology for high-precision mutation analysis of oncogenic and hereditary markers in clinical samples. The technology is based on ultra-deep sequencing of selectively enriched genomic regions, utilizing an optimized hybrid capture system to ensure maximum specificity, sensitivity, and uniform coverage.
The epicGEN portfolio includes hybrid capture-based NGS assays for both somatic oncology and hereditary disease applications. With a highly precise, ultra-sensitive, specific, and efficient, it is perfectly suited for clinical diagnostics and translational research, offering new advantages in the detection of complex genetic variations.
We offer user-friendly diagnostic NGS kits with an integrated software solution for somatic oncology and hereditary disease testing. The kits deliver exceptional analytical performance with optimized hybrid capture technology and fast, seamless processing, making them ideal for laboratories of any size.
Completing the workflow from sample to variant reporting, GENOVESA is a cloud-based, all-in-one solution for FASTQ data analysis across the entire epicGEN and fastGEN portfolio.
Complementary technologies and applications
BioVendor Group also offers additional solutions to support a wider range of testing applications:
The portfolio includes the 16S Microbiome + ITS NGS Assay, based on targeted 16S and ITS amplification, supported by the Microbiome Analysis Webtool for automated taxonomic classification and beta diversity analysis (learn more).
Our Molecular Diagnostics portfolio also includes technologies such as RealFast Assays and StripAssay (learn more).